Ontology highlight
ABSTRACT: Background
Many epidemiologic studies have investigated the association between carotenoids intake and risk of Prostate cancer (PCa). However, results have been inconclusive.Methods
We conducted a systematic review and dose-response meta-analysis of dietary intake or blood concentrations of carotenoids in relation to PCa risk. We summarized the data from 34 eligible studies (10 cohort, 11 nested case-control and 13 case-control studies) and estimated summary Risk Ratios (RRs) and 95% confidence intervals (CIs) using random-effects models.Results
Neither dietary ?-carotene intake nor its blood levels was associated with reduced PCa risk. Dietary ?-carotene intake and lycopene consumption (both dietary intake and its blood levels) were all associated with reduced risk of PCa (RR for dietary ?-carotene intake: 0.87, 95%CI: 0.76-0.99; RR for dietary lycopene intake: 0.86, 95%CI: 0.75-0.98; RR for blood lycopene levels: 0.81, 95%CI: 0.69-0.96). However, neither blood ?-carotene levels nor blood lycopene levels could reduce the risk of advanced PCa. Dose-response analysis indicated that risk of PCa was reduced by 2% per 0.2mg/day (95%CI: 0.96-0.99) increment of dietary ?-carotene intake or 3% per 1mg/day (95%CI: 0.94-0.99) increment of dietary lycopene intake.Conclusions
?-carotene and lycopene, but not ?-carotene, were inversely associated with the risk of PCa. However, both ?-carotene and lycopene could not lower the risk of advanced PCa.
SUBMITTER: Wang Y
PROVIDER: S-EPMC4570783 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
Wang Yulan Y Cui Ran R Xiao Yuanyuan Y Fang Juemin J Xu Qing Q
PloS one 20150915 9
<h4>Background</h4>Many epidemiologic studies have investigated the association between carotenoids intake and risk of Prostate cancer (PCa). However, results have been inconclusive.<h4>Methods</h4>We conducted a systematic review and dose-response meta-analysis of dietary intake or blood concentrations of carotenoids in relation to PCa risk. We summarized the data from 34 eligible studies (10 cohort, 11 nested case-control and 13 case-control studies) and estimated summary Risk Ratios (RRs) and ...[more]